Skip to main content
Clinical Trials/NCT03105466
NCT03105466
Unknown
Not Applicable

Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

Zhongshan Ophthalmic Center, Sun Yat-sen University1 site in 1 country50 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Deep anterior lamellar keratoplasty
Conditions
Corneal Transplantation
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Enrollment
50
Locations
1
Primary Endpoint
the changes of Best corrected visual acuity
Last Updated
9 years ago

Overview

Brief Summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis.

Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
February 2020
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jin Yuan

Professor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • corneal diseases not involving the endothelial layer

Exclusion Criteria

  • corneal diseases involving the endothelial layer
  • allergic to pig tissue
  • do not accept xenotransplantation

Arms & Interventions

Acellular porcine cornea group

Participants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea

Intervention: Deep anterior lamellar keratoplasty

Acellular porcine cornea group

Participants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea

Intervention: Acellular Porcine Cornea

Acellular porcine cornea group

Participants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea

Intervention: Tacrolimus eye drops

Acellular porcine cornea group

Participants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea

Intervention: Tobradex eyedrops

Outcomes

Primary Outcomes

the changes of Best corrected visual acuity

Time Frame: Before surgery, 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

Secondary Outcomes

  • the changes of visual contrast sensitivity(Before surgery, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery)
  • the changes in the transparency of graft(1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery)
  • The changes in corneal thickness depth(1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery)
  • The changes in corneal nerve regeneration(1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery)
  • The changes of depression and anxiety status(Before surgery, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery)

Study Sites (1)

Loading locations...

Similar Trials